Detalhe da pesquisa
1.
Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.
Proc Natl Acad Sci U S A
; 119(49): e2213146119, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449545